Two patients who did not qualify as treatment success had an efficacy score of 3 (inconclusive): with CRP elevation due to concurrent urinary tract infection and a small CRP pre-value in one patient each, and these were not judged as treatment failures for PVO. The gene discussed is CRP; the disease is urinary tract infection.